{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T10:42:05Z","timestamp":1772707325292,"version":"3.50.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T00:00:00Z","timestamp":1632960000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T00:00:00Z","timestamp":1632960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The aim of present study was to assess the karyotypes of amniotic fluid cells and find the frequency of chromosomal abnormalities and their significance in clinical setting. A total of 15,401 pregnant women were assessed from March 2016 to May 2019, and 14,968 amniotic fluid samples were successfully cultured. These fetuses were grouped according to different indications including advanced maternal age, abnormal nuchal translucency (NT) values, positive first\/second trimester screening results, high risk NIPT results, very low PAPP-A and free \u03b2-hCG multiples of the normal median (MoM) results, abnormal ultrasound findings or previous history of chromosomal abnormalities. Results indicated the presence of normal karyotype in 90.2% (13,497\/14,968) of fetuses. Totally, 46.4% (6945\/14,968) of fetuses were 46,XX and 43.8% (6552\/14,968) had 46,XY chromosome pattern. A total of 1077 abnormal karyotypes were found among 14,968 fetuses, thus the rate of abnormal fetuses was calculated to be 7.2% (1072\/14,968). Meanwhile, a total of 394 cases (2.8%) had a normal polymorphism in their karyotype. In other words, abnormal karyotypes were detected in one of 13.9 cases of patients underwent amniocentesis. Down syndrome, Edward\u2019s syndrome, abnormal mosaicisms and Patau\u2019s syndrome were detected in 4.4% (659\/14,968), 0.57% (85\/14,968), 0.49% (74\/14,968) and 0.24% (36\/14,968) of cases, respectively. Sex chromosomal abnormalities including Klinefelter syndrome, Turner syndrome and 47,XXX karyotype were detected in 64 cases (0.43%). In this article, the rates of chromosomal abnormalities are compared between different groups of patients based on the advanced maternal age, abnormal NT values, very low PAPP-A and free \u03b2-hCG MoMs results, and positive FTS results. The current investigation provides insight into the most appropriate indications for amniocentesis in Iran.<\/jats:p>","DOI":"10.1038\/s41598-021-98928-3","type":"journal-article","created":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T10:30:41Z","timestamp":1632997841000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Karyotype analysis of amniotic fluid cells and report of chromosomal abnormalities in 15,401 cases of Iranian women"],"prefix":"10.1038","volume":"11","author":[{"given":"Sarang","family":"Younesi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Mahdi","family":"Taheri Amin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sedigheh","family":"Hantoushzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pourandokht","family":"Saadati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soudabeh","family":"Jamali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad-Hossein","family":"Modarressi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahram","family":"Savad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeed","family":"Delshad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saloomeh","family":"Amidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taraneh","family":"Geranorimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fariba","family":"Navidpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soudeh","family":"Ghafouri-Fard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,30]]},"reference":[{"key":"98928_CR1","doi-asserted-by":"publisher","first-page":"9352581","DOI":"10.1155\/2019\/9352581","volume":"2019","author":"T Hu","year":"2019","unstructured":"Hu, T. et al. Chromosomal aberrations in pediatric patients with developmental delay\/intellectual disability: A single-center clinical investigation. Biomed. Res. Int. 2019, 9352581. https:\/\/doi.org\/10.1155\/2019\/9352581 (2019).","journal-title":"Biomed. Res. Int."},{"key":"98928_CR2","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.siny.2015.07.002","volume":"20","author":"IC Verma","year":"2015","unstructured":"Verma, I. C. & Puri, R. D. Global burden of genetic disease and the role of genetic screening. Semin. Fetal Neonatal. Med. 20, 354\u2013363. https:\/\/doi.org\/10.1016\/j.siny.2015.07.002 (2015).","journal-title":"Semin. Fetal Neonatal. Med."},{"key":"98928_CR3","doi-asserted-by":"crossref","unstructured":"Committee Opinion No.682: Microarrays and next-generation sequencing technology: The use of advanced genetic diagnostic tools in obstetrics and gynecology. Obstetr. Gynecol. 128, e262\u2013268 (2016)","DOI":"10.1097\/AOG.0000000000001817"},{"key":"98928_CR4","doi-asserted-by":"publisher","unstructured":"Wang, L. et al. Application and evaluation of invasive prenatal diagnostic techniques and analysis of chromosomal karyotype. J. Centr. South Univ. Med. Sci. 38, 400\u2013404. https:\/\/doi.org\/10.3969\/j.issn.1672-7347.2013.04.011 (2013)","DOI":"10.3969\/j.issn.1672-7347.2013.04.011"},{"key":"98928_CR5","first-page":"644","volume":"46","author":"YP Zhang","year":"2011","unstructured":"Zhang, Y. P. et al. Karyotype analysis of amniotic fluid cells and comparison of chromosomal abnormality rate during second trimester. Zhonghua Fu Chan Ke Za Zhi 46, 644\u2013648 (2011).","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"98928_CR6","first-page":"126","volume":"48","author":"H Li","year":"2019","unstructured":"Li, H., Li, Y., Zhao, R. & Zhang, Y. Cytogenetic analysis of amniotic fluid cells in 4206 cases of high-risk pregnant women. Iran. J. Public Health 48, 126\u2013131 (2019).","journal-title":"Iran. J. Public Health"},{"key":"98928_CR7","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3109\/01443615.2015.1041889","volume":"36","author":"H Xiao","year":"2016","unstructured":"Xiao, H. et al. Karyotype analysis with amniotic fluid in 12365 pregnant women with indications for genetic amniocentesis and strategies of prenatal diagnosis. J. Obstetr. Gynaecol. 36, 293\u2013296. https:\/\/doi.org\/10.3109\/01443615.2015.1041889 (2016).","journal-title":"J. Obstetr. Gynaecol."},{"key":"98928_CR8","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1590\/S1415-47572008000500004","volume":"31","author":"RG Kessler","year":"2008","unstructured":"Kessler, R. G., Sanseverino, M. T. V., Leistner-Segal, S., Magalh\u00e3es, J. A. & Giugliani, R. Prenatal diagnosis of fetal chromosomal abnormalities: Report of an 18-year experience in a Brazilian public hospital. Genet. Mol. Biol. 31, 829\u2013833 (2008).","journal-title":"Genet. Mol. Biol."},{"key":"98928_CR9","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/(SICI)1096-8628(19990115)82:2<149::AID-AJMG10>3.0.CO;2-L","volume":"82","author":"L Caron","year":"1999","unstructured":"Caron, L., Tihy, F. & Dallaire, L. Frequencies of chromosomal abnormalities at amniocentesis: Over 20 years of cytogenetic analyses in one laboratory. Am. J. Med. Genet. 82, 149\u2013154 (1999).","journal-title":"Am. J. Med. Genet."},{"key":"98928_CR10","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/uog.14691","volume":"45","author":"K Kagan","year":"2015","unstructured":"Kagan, K., Wright, D. & Nicolaides, K. First-trimester contingent screening for trisomies 21, 18 and 13 by fetal nuchal translucency and ductus venosus flow and maternal blood cell-free DNA testing. Ultrasound Obstet. Gynecol. 45, 42\u201347 (2015).","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"98928_CR11","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/uog.18979","volume":"51","author":"A Lindquist","year":"2018","unstructured":"Lindquist, A., Poulton, A., Halliday, J. & Hui, L. Prenatal diagnostic testing and atypical chromosome abnormalities following combined first-trimester screening: implications for contingent models of non-invasive prenatal testing. Ultrasound Obstet. Gynecol. 51, 487\u2013492 (2018).","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"98928_CR12","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1002\/uog.17548","volume":"51","author":"I Vogel","year":"2018","unstructured":"Vogel, I. et al. Chromosomal microarray as primary diagnostic genomic tool for pregnancies at increased risk within a population-based combined first-trimester screening program. Ultrasound Obstet. Gynecol. 51, 480\u2013486 (2018).","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"98928_CR13","first-page":"145","volume":"51","author":"RS Verma","year":"1987","unstructured":"Verma, R. S. & Huq, A. Sex ratio of children with trisomy 21 or Down syndrome. Cytobios 51, 145\u2013148 (1987).","journal-title":"Cytobios"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98928-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98928-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98928-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T16:17:25Z","timestamp":1670084245000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98928-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,30]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["98928"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-98928-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,30]]},"assertion":[{"value":"21 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19402"}}